High-risk MDS Therapy

Guadecitabine (SGI-110) Offers Potential New Treatment Option for Myelodysplastic Syndromes, Phase 2 Study Finds

Stella Richards 0Comment

Keywords 1. Guadecitabine 2. Myelodysplastic Syndromes Treatment 3. Hypomethylating Agents 4. Phase 2 Clinical Trial…

Read More

Exploring the Link Between Nociplastic Pain and Pain-Motivated Drinking in Individuals with Alcohol Use Disorder – A Study

Breakthrough in Inflammation Treatment: New Anti-Inflammatory Compounds from Andrographis paniculata Unveiled

Salinity in Flux: Decoding the Genetic Adaptations of Artemia in Qinghai-Tibet Plateau’s Changing Salt Lake

A Deep Dive into the Impact of COVID-19 Vaccination on Abnormal Uterine Bleeding: Insights from a Major Health Study